Oncology Treatments in Cuba

Cuba has managed to attract the attention of the world with the vaccines it has developed in the treatment of cancer. There are vaccine treatments and alternative treatments in Cuba for many types of cancer, especially lung cancer.

According to the World Health Organization, Cuban researchers working in the field of biotechnology have made significant progress in developing cancer prevention methods and treatments, transforming cancer from a deadly disease into a chronic disease. Vaccines and treatments developed in Cuba have been the subject of scientific studies in the USA and other countries in recent years.


All cancer types can be evaluated for alternative programs in Cuba. However, Cuban vaccines, developed by Cuban experts and having wide repercussions in the world, are applied for certain types of cancer.

Current diagnoses for the Cuban vaccine:

​ ​

  • Lung cancer (non-small cell)

  • Head/neck cancers

  • pancreatic cancer

  • Gastric cancer

  • Esophageal cancer

  • Colon cancer

  • Skin cancer (basal cell)


All of these diagnoses can also be evaluated for Cuba's quality of life improvement programme.



Nimotuzumab (CIMAher)

Head, neck, pancreas, stomach, colon, esophagus vaccine


For cancer types with excessive EGFR (epidermal growth factor receptor) production, target therapy containing anti-EGFR antibodies is the only non-chemo therapy used against this disease.


CimaVax - EGF

Non-Small Cell Lung Cancer Vaccine

The Non-Small Cell Lung Cancer vaccine CimaVax EGF is the product of a 25-year research program developed by the Center for Molecular Immunology, Genetic Engineering and Biotechnology in Cuba.


Racotumomab (Vaxira)

Non-Small Cell Lung Cancer Vaccine


The Non-Small Cell Lung Cancer vaccine Racotumomab is the second non-small cell lung cancer (NSCLC) vaccine developed by the Center for Molecular Immunology in Cuba and was used as the primary treatment for non-small cell lung cancer in Cuba until January 2013.




It is a method that has been put into practice by reducing the blue scorpion venom, which is common with the homoeopathic treatment method applied in Cuba. VIDATOX is an adjunct therapy in the treatment of various oncology. This drug relieves pain by strengthening the patient's immune system, improves the quality of life by eliminating chemotherapy - radiotherapy symptoms.



Hebertrans has been used for adjuvant purposes in cancer patients to enhance their immunity. Positive development of this immunotherapy associated with natural products has been reported.


  • Nimotuzumab(CIMAher) : $9,530 (6 doses)

  • Vaxira and CimaVax : $4,365  (5 doses)

The prices mentioned above are for drugs only. Service fees are determined after approval from the Cuban Ministry of Health.​


Registration is easy.  Follow the steps and we will get in touch with you shortly to advise you further.